Drug‐induced peripheral oedema: An aetiology‐based review - Archive ouverte HAL
Article Dans Une Revue British Journal of Clinical Pharmacology Année : 2021

Drug‐induced peripheral oedema: An aetiology‐based review

Bérenger Largeau
Céline Lengellé
  • Fonction : Auteur
Bénédicte Sautenet
  • Fonction : Auteur
Annie‐pierre Jonville-Béra
  • Fonction : Auteur

Résumé

Many drugs are responsible, through different mechanisms, for peripheral oedema. Severity is highly variable, ranging from slight oedema of the lower limbs to anasarca pictures as in the capillary leak syndrome. Although most often noninflammatory and bilateral, some drugs are associated with peripheral oedema that is readily erythematous (eg, pemetrexed) or unilateral (eg, sirolimus). Thus, drug‐induced peripheral oedema is underrecognized and misdiagnosed, frequently leading to a prescribing cascade. Four main mechanisms are involved, namely precapillary arteriolar vasodilation (vasodilatory oedema), sodium/water retention (renal oedema), lymphatic insufficiency (lymphedema) and increased capillary permeability (permeability oedema). The underlying mechanism has significant impact on treatment efficacy. The purpose of this review is to provide a comprehensive analysis of the main causative drugs by illustrating each pathophysiological mechanism and their management through an example of a drug.

Dates et versions

hal-04760250 , version 1 (30-10-2024)

Identifiants

Citer

Bérenger Largeau, Jean‐luc Cracowski, Céline Lengellé, Bénédicte Sautenet, Annie‐pierre Jonville-Béra. Drug‐induced peripheral oedema: An aetiology‐based review. British Journal of Clinical Pharmacology, 2021, 87 (8), pp.3043-3055. ⟨10.1111/bcp.14752⟩. ⟨hal-04760250⟩

Collections

UGA
4 Consultations
0 Téléchargements

Altmetric

Partager

More